Recommendations for Follow Up After OneTest™

Endometrial Cancer

Elevated Biomarkers:

  • CA 125
  • HE 4

Symptoms:

  • Abnormal vaginal bleeding, such as bleeding between periods, after menopause, or after sex.
  • Pelvic pain or discomfort
  • Pain during intercourse
  • Unexplained weight loss
  • Fatigue

Signs:

  • Enlarged uterus
  • Enlarged lymph nodes in the pelvis

Risk Factors

  • Age: The risk of endometrial cancer increases with age, with most cases occurring in women aged 50 and older.
  • Obesity: Being overweight or obese increases the risk, especially if the excess weight is carried around the abdomen.
  • Hormone Replacement Therapy (HRT): Long-term use of estrogen without progesterone increases the risk.
  • Diabetes: Having diabetes increases the risk, especially if it is poorly controlled.
  • Polycystic Ovary Syndrome (PCOS): Having PCOS increases the risk.
  • Family History: Having a first-degree relative (parent, sibling, or child) with endometrial cancer increases the risk.
  • Previous cancer treatment: Previous treatment with tamoxifen, a drug used to treat breast cancer, increases the risk
  • Lynch syndrome: An inherited genetic condition that increases the risk of several types of cancer, including endometrial cancer

Other Screening Tools:

  • Pelvic ultrasound: Recommended for individuals with risk factors for endometrial cancer or symptoms suggestive of endometrial cancer.
  • Endometrial biopsy: Recommended if abnormalities are detected during a pelvic ultrasound or if endometrial cancer is suspected.
  • Imaging tests (CT scan, MRI): Recommended for individuals with risk factors for endometrial cancer or symptoms suggestive of endometrial cancer.

Next Exam(s) To Do

  • Ultrasound: If OneTest Indicates elevated predictive risk for endometrial cancer, an abdominal or transvaginal ultrasound would be performed for further evaluation.
Shopping Basket